Peer Review History
| Original SubmissionAugust 24, 2024 |
|---|
|
Dear Dr. Zhang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Amal Diab Ghanem Atalla, ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: This work was Supported by Special Research Cultivation Fund for Clinical Nursing of Wuhan University, Project LCHL202327. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. "In the online submission form, you indicated that the data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy orethical restrictions. All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 4. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. Additional Editor Comments : Dear Author, Thank you for submitting your manuscript titled "[Title of Manuscript]." We have received comprehensive feedback from the reviewers, which provides constructive insights to further improve the quality and clarity of your work. We kindly request you to carefully revise the manuscript in accordance with their comments and suggestions. Please ensure that all points raised by the reviewers are addressed thoroughly, and where necessary, provide a detailed explanation for any comments that cannot be fully implemented. Once revised, please include a response letter summarizing the changes made and how each reviewer’s comment has been addressed. We look forward to receiving your revised submission. Best regards, [Amal Diab] [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: thank you for your effort to modify your article in form that improvment make it very useful in increasing body of knowlege thanks again and keep going , but i finnaly recommend minir english revision to improve rediability of your manuscript Reviewer #2: Thanks for inviting me for reviewing this topic Please consider the following: - clarify more practical implications for nursing in abstract and implications section - introduction: the significance of the study need to be highlighted and more clarified - clarify more the rationale for selecting such settings with detailed description. - reliability and pilot study clarify whether it is from the same study hospital or different one?? - Implications for practice need to be modified to more applicable actions - clarify more strengths and limitations of the study Reviewer #3: One point should be considered for using more updated references 2023-2024 in the literature. The sampling should be discussed in detail with references. The discussion should link all variables of the study with literature and results. More variables should be included in the study to make it stronger. some paragraph need to add references. You need to justify to make it clear to generalize your results. Data Collection need more details. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Mostafa shaban Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Zhang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: ============================== Please submit your revised manuscript by May 16 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Professor Amal Diab Ghanem Atalla Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear Author Following our review of your manuscript, we have identified minor revisions that will enhance its clarity and readability. These revisions primarily involve grammar editing, proofreading, and slight refinements to improve sentence structure, coherence, and overall flow. While these changes do not affect the core findings or conclusions of your study, they will ensure a polished and professional presentation. We kindly request that you review and incorporate these revisions before resubmitting the manuscript. Should you need any clarification, please do not hesitate to reach out. Thank you for your efforts, and we look forward to receiving the revised version. Best regards [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: (No Response) Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #4: Yes ********** Reviewer #2: Areas for Improvement: 1. Abstract & Introduction The abstract lacks clarity in describing key findings in a concise manner. Recommendation: Summarize the major statistical results more succinctly while emphasizing the study’s novelty. The introduction provides a broad background but could benefit from a stronger justification for why self-efficacy was chosen as a mediating/moderating factor. Recommendation: Strengthen the theoretical underpinning for why self-efficacy is expected to influence both attitudes and behavior in palliative care. 2. Methodology The study relies entirely on self-reported measures, which can introduce bias. Recommendation: Acknowledge this limitation more explicitly and suggest potential complementary methods, such as observational studies or supervisor evaluations. The justification for using SPSS PROCESS for mediation analysis is not clearly articulated. Recommendation: Briefly explain why this statistical approach was chosen over alternatives like Structural Equation Modeling (SEM). 3. Results & Interpretation The mediation effect (34.81%) is moderate but not overwhelmingly strong. This nuance is not discussed. Recommendation: Interpret the mediation effect in the context of previous studies—how does this compare with similar research? While the moderation model is statistically significant, the practical significance (effect size) is not explicitly discussed. Recommendation: Provide effect size measures to contextualize the practical importance of the findings. 4. Discussion & Implications The discussion restates results but lacks deeper engagement with alternative explanations. Recommendation: Consider potential confounders, such as institutional culture or workload, that may have influenced results. The discussion does not address cultural factors in China that may impact attitudes toward palliative care. Recommendation: Include a brief discussion on cultural attitudes towards end-of-life care and whether findings might differ in other healthcare systems. 5. Limitations & Future Directions The limitations section is well-structured but could mention response bias more explicitly. Recommendation: Suggest future studies incorporating mixed-methods approaches to mitigate self-reporting bias. Final Recommendation: Accept with Minor Revisions Improve clarity in abstract and introduction. Provide deeper discussion on effect sizes and alternative explanations. Address cultural considerations and response bias more explicitly. This study has strong potential and makes a meaningful contribution to palliative care research. With these refinements, it would be even stronger. Reviewer #4: Dear authors, thank you for trying to deepen the knowledge within your topic, I have taken great interest in reading your work. - Please ensure that your manuscript meets all requirements - The title is very critical and important, additionally it covers an extra point of research not covered in previous research. - Introduction; it well constructed please focus on paraphrasing - Methodology: Please mention more specifically why select these two hospitals - Data collection process very short give more clarification about actual process regarding the duration to fill every sheet, additionally how you decrease the bias during data collection process, Moreover, more clarification about the role of co-investigators -The Palliative Care Graded Diagnosis and Treatment Knowledge, Attitudes, and Practices tool please tension about this paragraph “In the knowledge dimension, participants were primarily surveyed on their knowledge of palliative care graded diagnosis and treatment, rated on a 5-point scale (1 = strongly disagree, 5 = strongly agree). Higher scores indicate more positive attitudes towards palliative care graded diagnosis and treatment. The behavior dimension consists of 13 items, rated from 1(very rarely) to 5(always), with higher scores indicating more proactive engagement in palliative care graded diagnosis and treatment. “ please more clarification about the three dimensions in this tool about how many items in each dimension because you mention knowledge dimension and you mention this dimension used to assess attitude and you didn’t mention the attitude dimension itself and how many items????. - In the General Self-Efficacy Scale (GSES), developed by Ralf Schwarzer, was used to measure nurses’ self-efficacy , you didn’t mention the Ralf Schwarzer article in the reference section - What about pilot sample ? - This manuscript requires additional editing and proofreading to correct detected errors - Please add DOI in some references I wish you successfully continued work with your manuscript! ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: Yes: Samia Roshdy Soliman Osman Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Dear Dr. Zhang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 19 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mohammed Elsayed Zaky, Ph.D Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed Reviewer #5: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes Reviewer #5: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes Reviewer #5: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes Reviewer #5: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #5: Yes ********** Reviewer #2: (No Response) Reviewer #5: The study addresses a highly relevant and underexplored topic, offering valuable insights into the psychosocial dynamics affecting palliative care practices among nurses. The use of a moderated mediation model enhances the conceptual strength of the manuscript. However, several aspects would benefit from improved clarity, methodological detail, and consistency in reporting. The following specific comments are intended to support the refinement of your manuscript. • The manuscript inconsistently uses the terms “grading treatment,” “graded diagnosis and treatment,” and “triage.” Therefore standardize terminology throughout. If "graded diagnosis and treatment" is a unique model in China, define it clearly early on and use it consistently (e.g., "graded treatment"). If you intend to use "triage" as a broader concept, clarify its equivalence or difference with "graded treatment." • Condense the aims into a single, cohesive paragraph. For example: "This study aims to (1) examine the relationship between healthcare professionals’ attitudes and behaviors regarding palliative care grading treatment and the mediating role of self-efficacy, and (2) explore whether self-efficacy moderates the effect of compassion fatigue on well-being at work." • Improve Background Flow by streamline by grouping related ideas (e.g., barriers to palliative care delivery, role of healthcare professionals, system-level challenges) into more cohesive thematic sections. You can use updated studies in the background “Toqan D, Malak MZ, Ayed A, Hamaideh SH, Al-Amer R. Perception of nurses’ knowledge about Palliative Care in West Bank/Palestine: levels and influencing factors. Journal of palliative care. 2023 Jul;38(3):336-44”. “Awad B, Batran A, Malak MZ, Ayed A, Shehadeh A, Alassoud B, Ejheisheh MA. Knowledge, attitudes, and self-efficacy regarding palliative care among Palestinian nurses in intensive care units. BMC nursing. 2025 Apr 17;24(1):435”. • Sharpen the Justification for the Study "To our knowledge, this is among the first studies to assess both the mediating and moderating roles of self-efficacy in the context of palliative care treatment grading in China, filling a critical gap in understanding the psychosocial mechanisms behind healthcare professionals' behaviors." • Change “To investigates” to “To investigate” in Aims. Change “triage attitude” to “attitudes toward graded treatment” (if this is the consistent term). • Design ??? • Population and procedure: The text mentions distributing 900 surveys and completing 890, but later also says 900 were distributed and 742 were valid—consider clarifying this sequence for better coherence. • Ethical approval : Clarify confidentiality procedures: You may elaborate slightly on how identification numbers were used (e.g., coded, encrypted). • Measurement tools: Cronbach’s alpha placement: Mention the reliability coefficient at the end of each scale section for clarity. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No Reviewer #5: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org
|
| Revision 3 |
|
Healthcare Providers' Palliative Care Graded Diagnosis and Treatment Behavior, Attitudes, Self-efficacy, Compassion Fatigue, and Workplace Well-being�A Mediating Moderation Model PLOS ONE Dear Dr. Zhang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 03 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Majed Sulaiman Alamri, PhD Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #5: All comments have been addressed Reviewer #6: All comments have been addressed Reviewer #7: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #5: Yes Reviewer #6: Yes Reviewer #7: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #5: Yes Reviewer #6: Yes Reviewer #7: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #5: Yes Reviewer #6: Yes Reviewer #7: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #5: Yes Reviewer #6: Yes Reviewer #7: Yes ********** Reviewer #5: the authors adequately addressed my comments raised in a previous round of review and the language is clear, correct, and unambiguous Reviewer #6: The revised manuscript (PONE-D-24-35851R3) has successfully addressed all comments. The changes are substantial and significantly improve the quality, clarity, and academic rigor of the paper. The most important change, the consistent use of "graded diagnosis and treatment", has been implemented correctly. The manuscript is now in a much stronger position for acceptance. The remaining items are very minor typographical edits that can be caught in a final proofread before resubmission. Reviewer #7: Dear authors, The topic you have done is important Some comments First, tracking and having two versions within one document was time-consuming; you should provide only what you amended, and those with accepting changes in font and colour should not appear. Some grammar needs to be checked; for example, self-efficacy is an individual's ability of to execute and control the influences of their environment at a predetermined level [19]. 900 healthcare providers or nurses? The abstract mentioned healthcare providers. Also, in discussion healthcare providers. Clearly distinguish which subscales were analysed; only attitude was seen in the analysis. (KAP?) In discussion, self-efficacy’s protective role is repeated across multiple paragraphs. Overly repetitive Maybe you need a paragraph connecting findings to training and policy interventions more explicitly. The last version is improved compared to the original one. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #5: No Reviewer #6: No Reviewer #7: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 4 |
|
Healthcare Providers' Palliative Care Graded Diagnosis and Treatment Behavior, Attitudes, Self-efficacy, Compassion Fatigue, and Workplace Well-being�A Mediating Moderation Model PONE-D-24-35851R4 Dear Dr. Zhang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Majed Sulaiman Alamri, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #5: All comments have been addressed Reviewer #6: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #5: Yes Reviewer #6: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #5: Yes Reviewer #6: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #5: Yes Reviewer #6: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #5: Yes Reviewer #6: Yes ********** Reviewer #5: the authors do all comments. The manuscript described a technically sound piece of scientific research with data supported the conclusions. the language is clear, correct, and unambiguous. no comments Reviewer #6: The study is well-conceived and makes a valuable contribution to the literature on palliative care. The cross-sectional design and self-report measures are appropriately acknowledged as limitations. The manuscript is methodologically sound, ethically compliant, and presents its findings clearly. I have no further concerns and recommend acceptance for publication. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #5: No Reviewer #6: No ********** |
| Formally Accepted |
|
PONE-D-24-35851R4 PLOS ONE Dear Dr. Zhang, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Majed Sulaiman Alamri Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .